Overall, this study contributes to our understanding of the biology of nausea and vomiting in pregnancy and may lead to future research evaluating new treatment avenues. Of note, drugs targeting the GDF15 pathway have shown great promise in mitigating weight loss, loss of appetite, and vomiting in animal models and are currently in clinical trials in cancer cachexia, a disease with similar symptoms to HG.
Read MoreHyperemesis Gravidarum (HG) is not self-limiting, and its impact can last a lifetime for mothers and their children. Until there is recognition of this fact and comprehensive, universal, effective treatment for all HG patients, every level of society will continue to face the costs of HG.
Read MoreFebruary is Heart Health Month, and the HER Foundation shares 4 ways for you to protect your heart.
Read MoreMay 15th is International HG Awareness Day and HG Reality. You can help the HER Foundation raise awareness and educate about your HG Reality!
Read MoreDr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world.
Read MoreBe a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
Read MoreTrauma from Hyperemesis Gravidarum (HG) cannot be prevented. The HER team believes the following tips will give you the best chance of being prepared for HG and reduce trauma in…
Read MoreIn 2023, we will continue our support of families across the globe, continue our groundbreaking research, advocate to change policy to improve maternal and fetal outcomes, and launch an exciting new education program!
Read More